Dx Deal Review 2024
2024: The Year of AI-Driven Early Detection, Multi-Omic Data Integration, and Precision Diagnostics.
Dx Deal Review 2024
Download Request
2024: The Year of AI-Driven Early Detection, Multi-Omic Data Integration, and Precision Diagnostics.
Download Request
The US biopharma VC landscape has been transformed over the last four years. The free-flowing capital of the pandemic sugar rush era peaked in Q4 2020, after which the IPO window snapped firmly shut in the last quarters of 2022. The next year for biotech was even worse in most respects: IPOs down, VC down, M&A down, licensing deals down. However, despite lower deal numbers and total capital deployment, reported valuations appeared to hold firm and start recovering in late 2023. This white paper provides insightful and in-depth analysis of the US biopharma VC landscape.
Download Request
Early detection, At-Home Testing and Smart Phone/ Wearable technology
Expanding non-invasive diagnostics in healthcare
Download Request
Over the past five years, the South Korean pharmaceutical and biotech sector has emerged as a hotbed for Licensing and Mergers and Acquisitions (M&A) activity, attracting interest from both domestic and international players. Its unprecedented growth is fuelled by a combination of innovation, government support, and market expansion strategies, alongside the strategic need to access advanced technologies and global markets. This white paper provides an in-depth analysis of the key trends, drivers, and notable transactions that have shaped this dynamic sector, and highlights how international companies can benefit from this thriving market.
Download Request
Leveraging Non-Invasive Testing in CNS and Endometriosis – Ongoing Research, Data Sharing
and AI Drive Diagnostic Innovations
Download Request
The European specialty pharma M&A landscape is undergoing significant transformations, with private equity firms facing new and unprecedented challenges. This white paper examines the current state of private equity within the sector, identifying the key obstacles and trends reshaping investment strategies.
Download Request